Get Involved
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
Study Purpose
This phase III trial studies cabozantinib to see how well it works compared with placebo in treating patients with neuroendocrine or carcinoid tumors that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Cabozantinib is a chemotherapy drug known as a tyrosine kinase inhibitor, and it targets specific tyrosine kinase receptors, that when blocked, may slow tumor growth.
Recruitment Criteria
|
Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms |
No |
|
Study Type
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes. Searching Both is inclusive of interventional and observational studies. |
Interventional |
| Eligible Ages | 18 Years and Over |
| Gender | All |
Inclusion Criteria:
- - Documentation of Disease: - Histologic Documentation: Well- or moderately-differentiated neuroendocrine tumors of pancreatic and non-pancreatic (i.e. carcinoid) origin by local pathology.
- - The pathology report must state ONE of the following: 1) well- or moderately-differentiated neuroendocrine tumor, 2) low- or intermediate-grade neuroendocrine tumor, or 3) carcinoid tumor or atypical carcinoid tumor; documentation of histology from a primary or metastatic site is allowed.
- - Patients with poorly differentiated neuroendocrine carcinoma, high-grade neuroendocrine carcinoma without specification of differentiation status, adenocarcinoid tumor, or goblet cell carcinoid tumor are not eligible.
- - Stage: Locally advanced/unresectable or metastatic disease.
- - Tumor Site: Histological documentation of neuroendocrine tumor of pancreatic, gastrointestinal (GI), lung, thymus, other, or unknown primary site; GI, lung, thymus, other, and unknown primary NETs will enroll in the carcinoid tumor cohort of the study.
- - Functional (i.e., associated with symptoms or clinical syndrome related to hormone secretion by tumor) or nonfunctional tumors are allowed.
- - Radiologic Evaluation: Target lesions must have shown evidence of disease progression by Response Evaluation Criteria in Solid Tumors (RECIST) version (v)1.1 criteria in the 12 months prior to registration; the radiologic images, imaging reports, and clinic notes indicating growth of existing lesions, development of new lesions, or treatment changes must be submitted.
- - Measurable Disease.
- - Patients must have measurable disease per RECIST 1.1 by computer tomography (CT) scan or magnetic resonance imaging (MRI) - Lesions must be accurately measured in at least one dimension (longest diameter to be recorded) as >= 1 cm with CT or MRI (or >= 1.5 cm for lymph nodes); non-measurable disease includes disease smaller than these dimensions or lesions considered truly non-measurable including: leptomeningeal disease, ascites, pleural or pericardial effusion, lymphangitic involvement of skin or lung.
- - Prior Treatment.
- - Patient must have experienced disease progression after receiving or intolerance leading to treatment discontinuation of at least one Food and Drug Administration (FDA)-approved line of therapy (except somatostatin analogs); prior lines of therapy must include one of the following: everolimus, sunitinib, or lutetium Lu 177 dotatate in patients with pancreatic NET; everolimus in patients with lung NET; everolimus or lutetium Lu 177 dotatate in patients with gastrointestinal NET.
- - Prior treatment (except somatostatin analogs) with biologic therapy, immunotherapy, chemotherapy, investigational agent for malignancy, and/or radiation must be completed at least 28 days prior to registration.
- - Prior treatment with somatostatin analogs is allowed, and continuation of treatment with somatostatin analogs while on cabozantinib/placebo is allowed provided that the patient has been on a stable dose for at least two months.
- - Prior systemic treatment with radionuclide therapy must be completed at least 6 weeks prior to registration.
- - Prior treatment with hepatic artery embolization (including bland embolization, chemoembolization, and selective internal radiation therapy) or ablative therapies is allowed if measurable disease remains outside of the treated area or if there is documented disease progression in a treated site; prior liver-directed or other ablative treatment must be completed at least 28 days prior to registration.
- - Prior treatment with cabozantinib is not allowed.
- - Patients should have resolution of any toxic effects of prior therapy (except alopecia and fatigue) to National Cancer Institute (NCI) CTCAE, version 5.0, grade 1 or less.
- - Patients must have completed any major surgery at least 12 weeks prior to registration and any minor surgery (including uncomplicated tooth extractions) at least 28 days prior to registration; complete wound healing from major surgery must have occurred at least 28 days prior to registration, and complete wound healing from minor surgery must have occurred at least 10 days prior to registration.
- - Patient History.
- - No class III or IV congestive heart failure (CHF) within 6 months of registration.
- - No clinically significant cardiac arrhythmia within 6 months of registration.
- - No unstable angina or myocardial infarction (MI) within 6 months of registration.
- - No thromboembolic events within 6 months of registration (including [incl.
- - No known history of congenital long QT syndrome.
- - No uncontrolled hypertension within 14 days of registration (defined as systolic blood pressure [SBP] >= 150 mmHg and/or diastolic blood pressure [DBP] >= 90 mmHg despite optimal medical management) - No clinically significant GI bleeding within 6 months of registration.
- - No clinically significant gastrointestinal abnormalities that may increase the risk for gastrointestinal bleeding within 6 months of registration including, but not limited to: active peptic ulcer, known endoluminal metastatic lesion(s) with history of bleeding, inflammatory bowel disease, or other gastrointestinal conditions with increased risk of perforation.
- - No GI perforation within 6 months of registration.
- - No known tumor with invasion into the GI tract from the outside causing increased risk of perforation or bleeding within 28 days of registration.
- - No radiologic or clinical evidence of pancreatitis.
- - No known cavitary lung lesions.
- - No known endobronchial lesions involving the main or lobar bronchi and/or lesions infiltrating major pulmonary vessels that increase the risk of pulmonary hemorrhage; (CT with contrast is recommended to evaluate such lesions) - No hemoptysis greater than 1/2 teaspoon (2.5 mL) or any other signs of pulmonary hemorrhage within the 3 months prior to registration.
- - No known tumor invading or encasing any major blood vessels.
- - No history of non-healing wounds or ulcers within 28 days of registration.
- - No history of fracture within 28 days of registration.
- - No brain metastases or cranial epidural disease unless adequately treated, stable, and off steroid support for at least 4 weeks prior to registration.
- - No known medical condition causing an inability to swallow oral formulations of agents.
- - No history of allergic reaction attributed to compounds of similar chemical or biological composition to cabozantinib/placebo.
- - No "currently active" second malignancy other than non-melanoma skin cancers or cervical carcinoma in situ; patients are not considered to have a "currently active" malignancy if they have completed therapy and are free of disease for >= 3 years.
- - Concomitant Medications.
- - Other planned concurrent investigational agents or other tumor directed therapies (chemotherapy, radiation) are not allowed while on this study.
- - Concurrent use of somatostatin analogs while on cabozantinib/placebo is allowed provided that the patient has been on a stable dose for at least two months.
- - Full dose oral anticoagulation/antiplatelet therapy is not permitted; low dose aspirin =< 81 mg/day is allowed; anticoagulation with therapeutic doses of low molecular weight heparin (LMWH) is allowed in patients who are on a stable dose of LMWH for at least 6 weeks prior to registration; treatment with warfarin is not allowed; anticoagulation in patients with brain metastases is not permitted.
- - Chronic concomitant treatment with strong inhibitors of CYP3A4 is not allowed; patients must discontinue the drug at least 14 days prior to registration on the study.
- - Chronic concomitant treatment with strong CYP3A4 inducers is not allowed; patients must discontinue the drug at least 14 days prior to registration on the study.
- - Not pregnant and not nursing.
- - Women of childbearing potential must have a negative pregnancy test done =< 14 days prior to registration.
- - A female of childbearing potential is a sexually mature female who: 1) has not undergone a hysterectomy or bilateral oophorectomy; or 2) has not been naturally postmenopausal for at least 12 consecutive months (i.e. has had menses at any time in the preceding 12 consecutive months) - Age >= 18 years.
- - Eastern Cooperative Oncology Group (ECOG) performance status: 0-2.
- - Absolute neutrophil count (ANC) >= 1,500/mm^3.
- - Hemoglobin >= 9 g/dL.
- - Platelet count >= 100,000/mm^3.
- - Prothrombin time (PT)/ international normalized ratio (INR), partial thromboplastin time (PTT) < 1.3 x upper limit of normal (ULN) - Aspartate aminotransferase (AST)/ alanine aminotransferase (ALT) =< 3 x ULN.
- - Total bilirubin =< 1.5 x ULN.
- - Except in the case of Gilbert disease, in which case total bilirubin must be =< 3 x ULN.
- - Creatinine =< 1.5 mg/dL OR creatinine clearance >= 45 mL/min.
- - Albumin >= 2.8 g/dL.
- - Potassium within normal limits (WNL) - Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal thyroid stimulating hormone (TSH), if free T4 is normal and patient is clinically euthyroid, patient is eligible.
- - Phosphorus WNL.
- - Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal TSH, if free T4 is normal and patient is clinically euthyroid, patient is eligible.
- - Calcium WNL.
- - Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal TSH, if free T4 is normal and patient is clinically euthyroid, patient is eligible.
- - Magnesium WNL.
- - Supplementation is acceptable to achieve a value WNL; in patients with low albumin levels, a corrected calcium value WNL is acceptable; in patients with abnormal TSH, if free T4 is normal and patient is clinically euthyroid, patient is eligible.
- - Urine protein to creatinine (UPC) ratio =< 1.
- - QT interval corrected for heart rate using Fridericia's formula (QTcF) =< 500 msec.
- - TSH WNL.
Trial Details
|
Trial ID:
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries. |
NCT03375320 |
|
Phase
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans. Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data. Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use. |
Phase 3 |
|
Lead Sponsor
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data. |
National Cancer Institute (NCI) |
|
Principal Investigator
The person who is responsible for the scientific and technical direction of the entire clinical study. |
Jennifer A Chan |
| Principal Investigator Affiliation | Alliance for Clinical Trials in Oncology |
|
Agency Class
Category of organization(s) involved as sponsor (and collaborator) supporting the trial. |
NIH |
| Overall Status | Active, not recruiting |
| Countries | United States |
|
Conditions
The disease, disorder, syndrome, illness, or injury that is being studied. |
Carcinoid Tumor, Functioning Pancreatic Neuroendocrine Tumor, Intermediate Grade Lung Neuroendocrine Neoplasm, Locally Advanced Digestive System Neuroendocrine Neoplasm, Locally Advanced Digestive System Neuroendocrine Tumor G1, Locally Advanced Lung Neuroendocrine Neoplasm, Locally Advanced Pancreatic Neuroendocrine Tumor, Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm, Low Grade Lung Neuroendocrine Neoplasm, Lung Neuroendocrine Tumor, Lung Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine Neoplasm, Metastatic Digestive System Neuroendocrine Tumor G1, Metastatic Lung Neuroendocrine Neoplasm, Metastatic Lung Neuroendocrine Tumor, Metastatic Pancreatic Neuroendocrine Neoplasm, Metastatic Pancreatic Neuroendocrine Tumor, Metastatic Thymus Neuroendocrine Neoplasm, Neuroendocrine Neoplasm, Neuroendocrine Tumor G2, Non-Functioning Pancreatic Neuroendocrine Tumor, Pancreatic Serotonin-Producing Neuroendocrine Tumor, Thymus Neuroendocrine Tumor, Unresectable Digestive System Neuroendocrine Neoplasm, Unresectable Digestive System Neuroendocrine Tumor G1, Unresectable Lung Neuroendocrine Neoplasm, Unresectable Pancreatic Neuroendocrine Neoplasm, Unresectable Thymus Neuroendocrine Neoplasm |
PRIMARY OBJECTIVES:
- I. To determine whether cabozantinib (cabozantinib S-malate) can significantly improve progression-free survival (PFS) compared to placebo in patients with advanced pancreatic neuroendocrine tumors (NET) whose disease has progressed after prior therapy.
- II. To determine whether cabozantinib can significantly improve progression-free survival (PFS) compared to placebo in patients with advanced carcinoid tumors whose disease has progressed after prior therapy.
- I. To determine whether cabozantinib can significantly improve overall survival (OS) compared to placebo in patients with advanced pancreatic NET whose disease has progressed after prior therapy.
- II. To determine whether cabozantinib can significantly improve overall survival (OS) compared to placebo in patients with advanced carcinoid tumors whose disease has progressed after prior therapy.
- III. To evaluate safety and tolerability of cabozantinib versus placebo in patients with advanced pancreatic NET using Common Terminology Criteria for Adverse Events (CTCAE) and Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
- IV. To evaluate safety and tolerability of cabozantinib versus placebo in patients with advanced carcinoid tumors using CTCAE and PRO-CTCAE.
- V. To evaluate the overall radiographic response rate of cabozantinib versus placebo in patients with advanced pancreatic NET whose disease has progressed after prior therapy.
- VI. To evaluate the overall radiographic response rate of cabozantinib versus placebo in patients with advanced carcinoid tumors whose disease has progressed after prior therapy.
- I. Results of the primary analysis will be examined for consistency, while taking into account the stratification factors and/or covariates of baseline quality of life (QOL) and fatigue.
- I. To compare overall quality of life, disease-related symptoms, and other domains between the two treatment groups (cabozantinib versus [vs.
- - A021602-HO1) POPULATION PHARMACOKINETICS SUBSTUDY OBJECTIVE: I.
- - A021602-PP1) OUTLINE: Patients are randomized to 1 of 2 arms.
Arms
Experimental: Arm I (cabozantinib S-malate)
Patients receive cabozantinib S-malate PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo blood and urine sample collection, and CT, MRI, and/or x-ray imaging during screening and on study.
Placebo Comparator: Arm II (placebo)
Patients receive placebo PO QD on days 1-28 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo blood and urine sample collection, and CT, MRI, and/or x-ray imaging during screening and on study. Patients may crossover to receive cabozantinib S-malate at the time of disease progression.
Interventions
Procedure: - Biospecimen Collection
Undergo blood and urine sample collection
Drug: - Cabozantinib S-malate
Given PO
Procedure: - Computed Tomography
Undergo CT
Procedure: - Magnetic Resonance Imaging
Undergo MRI
Other: - Placebo Administration
Given PO
Other: - Quality-of-Life Assessment
Ancillary studies
Procedure: - X-Ray Imaging
Undergo x-ray
Contact a Trial Team
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.
Status
Address
Katmai Oncology Group
Anchorage, Alaska, 99508
Status
Address
Kingman Regional Medical Center
Kingman, Arizona, 86401
Status
Address
Mayo Clinic Hospital in Arizona
Phoenix, Arizona, 85054
Status
Address
Banner University Medical Center - Tucson
Tucson, Arizona, 85719
Status
Address
University of Arizona Cancer Center-North Campus
Tucson, Arizona, 85719
Status
Address
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205
Status
Address
Kaiser Permanente-Deer Valley Medical Center
Antioch, California, 94531
Status
Address
PCR Oncology
Arroyo Grande, California, 93420
Status
Address
Sutter Auburn Faith Hospital
Auburn, California, 95602
Status
Address
Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, 94704
Status
Address
Mills-Peninsula Medical Center
Burlingame, California, 94010
Status
Address
City of Hope Comprehensive Cancer Center
Duarte, California, 91010
Status
Address
Epic Care-Dublin
Dublin, California, 94568
Status
Address
Epic Care Partners in Cancer Care
Emeryville, California, 94608
Status
Address
Kaiser Permanente-Fremont
Fremont, California, 94538
Status
Address
Palo Alto Medical Foundation-Fremont
Fremont, California, 94538
Status
Address
Kaiser Permanente-Fresno
Fresno, California, 93720
Status
Address
Contra Costa Regional Medical Center
Martinez, California, 94553-3156
Status
Address
Fremont - Rideout Cancer Center
Marysville, California, 95901
Status
Address
Memorial Medical Center
Modesto, California, 95355
Status
Address
Kaiser Permanente-Modesto
Modesto, California, 95356
Status
Address
Palo Alto Medical Foundation-Camino Division
Mountain View, California, 94040
Status
Address
Alta Bates Summit Medical Center - Summit Campus
Oakland, California, 94609
Status
Address
Kaiser Permanente-Oakland
Oakland, California, 94611
Status
Address
Palo Alto Medical Foundation Health Care
Palo Alto, California, 94301
Status
Address
Stanford Cancer Institute Palo Alto
Palo Alto, California, 94304
Status
Address
Kaiser Permanente-Redwood City
Redwood City, California, 94063
Status
Address
Kaiser Permanente-Richmond
Richmond, California, 94801
Status
Address
Kaiser Permanente-Roseville
Roseville, California, 95661
Status
Address
Sutter Roseville Medical Center
Roseville, California, 95661
Status
Address
Kaiser Permanente Downtown Commons
Sacramento, California, 95814
Status
Address
Sutter Medical Center Sacramento
Sacramento, California, 95816
Status
Address
University of California Davis Comprehensive Cancer Center
Sacramento, California, 95817
Status
Address
Kaiser Permanente-South Sacramento
Sacramento, California, 95823
Status
Address
Salinas Valley Memorial
Salinas, California, 93901
Status
Address
California Pacific Medical Center-Pacific Campus
San Francisco, California, 94115
Status
Address
Kaiser Permanente-San Francisco
San Francisco, California, 94115
Status
Address
UCSF Medical Center-Mission Bay
San Francisco, California, 94158
Status
Address
Kaiser Permanente-Santa Teresa-San Jose
San Jose, California, 95119
Status
Address
Kaiser Permanente San Leandro
San Leandro, California, 94577
Status
Address
Mills Health Center
San Mateo, California, 94401
Status
Address
Kaiser Permanente-San Rafael
San Rafael, California, 94903
Status
Address
Kaiser San Rafael-Gallinas
San Rafael, California, 94903
Status
Address
Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, 95051
Status
Address
Palo Alto Medical Foundation-Santa Cruz
Santa Cruz, California, 95065
Status
Address
Kaiser Permanente-Santa Rosa
Santa Rosa, California, 95403
Status
Address
Kaiser Permanente-South San Francisco
South San Francisco, California, 94080
Status
Address
Kaiser Permanente-Stockton
Stockton, California, 95210
Status
Address
Palo Alto Medical Foundation-Sunnyvale
Sunnyvale, California, 94086
Status
Address
Kaiser Permanente Medical Center-Vacaville
Vacaville, California, 95688
Status
Address
Kaiser Permanente-Vallejo
Vallejo, California, 94589
Status
Address
Sutter Solano Medical Center/Cancer Center
Vallejo, California, 94589
Status
Address
Kaiser Permanente-Walnut Creek
Walnut Creek, California, 94596
Status
Address
Rocky Mountain Cancer Centers-Aurora
Aurora, Colorado, 80012
Status
Address
Rocky Mountain Cancer Centers-Boulder
Boulder, Colorado, 80304
Status
Address
Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, 80907
Status
Address
National Jewish Health-Main Campus
Denver, Colorado, 80206
Status
Address
Rocky Mountain Cancer Centers-Midtown
Denver, Colorado, 80218
Status
Address
Saint Joseph Hospital - Cancer Centers of Colorado
Denver, Colorado, 80218
Status
Address
Rocky Mountain Cancer Centers-Rose
Denver, Colorado, 80220
Status
Address
Mountain Blue Cancer Care Center - Swedish
Englewood, Colorado, 80113
Status
Address
Swedish Medical Center
Englewood, Colorado, 80113
Status
Address
National Jewish Health-Western Hematology Oncology
Golden, Colorado, 80401
Status
Address
Saint Mary's Hospital and Regional Medical Center
Grand Junction, Colorado, 81501
Status
Address
Banner North Colorado Medical Center
Greeley, Colorado, 80631
Status
Address
Good Samaritan Hospital - Cancer Centers of Colorado
Lafayette, Colorado, 80026
Status
Address
Rocky Mountain Cancer Centers-Littleton
Littleton, Colorado, 80120
Status
Address
Rocky Mountain Cancer Centers-Sky Ridge
Lone Tree, Colorado, 80124
Status
Address
Banner McKee Medical Center
Loveland, Colorado, 80539
Status
Address
National Jewish Health-Northern Hematology Oncology
Thornton, Colorado, 80260
Status
Address
Intermountain Health Lutheran Hospital
Wheat Ridge, Colorado, 80401
Status
Address
Danbury Hospital
Danbury, Connecticut, 06810
Status
Address
Norwalk Hospital
Norwalk, Connecticut, 06856
Status
Address
MedStar Georgetown University Hospital
Washington, District of Columbia, 20007
Status
Address
GenesisCare USA - Aventura FP
Aventura, Florida, 33180
Status
Address
GenesisCare USA - Aventura
Aventura, Florida, 33180
Status
Address
GenesisCare USA - Boca Ration FP06
Boca Raton, Florida, 33431
Status
Address
Regional Cancer Center-Lee Memorial Health System
Fort Myers, Florida, 33905
Status
Address
Memorial Regional Hospital/Joe DiMaggio Children's Hospital
Hollywood, Florida, 33021
Status
Address
Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980
Status
Address
Moffitt Cancer Center
Tampa, Florida, 33612
Status
Address
Emory University Hospital Midtown
Atlanta, Georgia, 30308
Status
Address
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, 30322
Status
Address
Emory Saint Joseph's Hospital
Atlanta, Georgia, 30342
Status
Address
Hawaii Cancer Care - Westridge
'Aiea, Hawaii, 96701
Status
Address
Pali Momi Medical Center
'Aiea, Hawaii, 96701
Status
Address
Hawaii Cancer Care Inc - Waterfront Plaza
Honolulu, Hawaii, 96813
Status
Address
Queen's Cancer Cenrer - POB I
Honolulu, Hawaii, 96813
Status
Address
Queen's Medical Center
Honolulu, Hawaii, 96813
Status
Address
Straub Clinic and Hospital
Honolulu, Hawaii, 96813
Status
Address
Queen's Cancer Center - Kuakini
Honolulu, Hawaii, 96817
Status
Address
Kaiser Permanente Moanalua Medical Center
Honolulu, Hawaii, 96819
Status
Address
Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, 83706
Status
Address
Saint Luke's Cancer Institute - Boise
Boise, Idaho, 83712
Status
Address
Saint Alphonsus Cancer Care Center-Caldwell
Caldwell, Idaho, 83605
Status
Address
Kootenai Health - Coeur d'Alene
Coeur d'Alene, Idaho, 83814
Status
Address
Walter Knox Memorial Hospital
Emmett, Idaho, 83617
Status
Address
Saint Luke's Cancer Institute - Fruitland
Fruitland, Idaho, 83619
Status
Address
Idaho Urologic Institute-Meridian
Meridian, Idaho, 83642
Status
Address
Saint Luke's Cancer Institute - Meridian
Meridian, Idaho, 83642
Status
Address
Saint Alphonsus Cancer Care Center-Nampa
Nampa, Idaho, 83687
Status
Address
Saint Luke's Cancer Institute - Nampa
Nampa, Idaho, 83687
Status
Address
Kootenai Clinic Cancer Services - Post Falls
Post Falls, Idaho, 83854
Status
Address
Kootenai Clinic Cancer Services - Sandpoint
Sandpoint, Idaho, 83864
Status
Address
Saint Luke's Cancer Institute - Twin Falls
Twin Falls, Idaho, 83301
Status
Address
Illinois CancerCare-Bloomington
Bloomington, Illinois, 61704
Status
Address
Illinois CancerCare-Canton
Canton, Illinois, 61520
Status
Address
Illinois CancerCare-Carthage
Carthage, Illinois, 62321
Status
Address
University of Illinois
Chicago, Illinois, 60612
Status
Address
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, 60637
Status
Address
Carle at The Riverfront
Danville, Illinois, 61832
Status
Address
Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois, 62526
Status
Address
Illinois CancerCare-Dixon
Dixon, Illinois, 61021
Status
Address
Carle Physician Group-Effingham
Effingham, Illinois, 62401
Status
Address
Crossroads Cancer Center
Effingham, Illinois, 62401
Status
Address
Illinois CancerCare-Eureka
Eureka, Illinois, 61530
Status
Address
Illinois CancerCare-Galesburg
Galesburg, Illinois, 61401
Status
Address
Illinois CancerCare-Kewanee Clinic
Kewanee, Illinois, 61443
Status
Address
Illinois CancerCare-Macomb
Macomb, Illinois, 61455
Status
Address
Carle Physician Group-Mattoon/Charleston
Mattoon, Illinois, 61938
Status
Address
Loyola University Medical Center
Maywood, Illinois, 60153
Status
Address
UC Comprehensive Cancer Center at Silver Cross
New Lenox, Illinois, 60451
Status
Address
Cancer Care Center of O'Fallon
O'Fallon, Illinois, 62269
Status
Address
University of Chicago Medicine-Orland Park
Orland Park, Illinois, 60462
Status
Address
Illinois CancerCare-Ottawa Clinic
Ottawa, Illinois, 61350
Status
Address
Illinois CancerCare-Pekin
Pekin, Illinois, 61554
Status
Address
Illinois CancerCare-Peoria
Peoria, Illinois, 61615
Status
Address
Illinois CancerCare-Peru
Peru, Illinois, 61354
Status
Address
Illinois CancerCare-Princeton
Princeton, Illinois, 61356
Status
Address
Southern Illinois University School of Medicine
Springfield, Illinois, 62702
Status
Address
Springfield Clinic
Springfield, Illinois, 62702
Status
Address
Carle Cancer Center
Urbana, Illinois, 61801
Status
Address
Illinois CancerCare - Washington
Washington, Illinois, 61571
Status
Address
Memorial Hospital of South Bend
South Bend, Indiana, 46601
Status
Address
University of Iowa Healthcare Cancer Services Quad Cities
Bettendorf, Iowa, 52722
Status
Address
Mercy Hospital
Cedar Rapids, Iowa, 52403
Status
Address
Oncology Associates at Mercy Medical Center
Cedar Rapids, Iowa, 52403
Status
Address
Mercy Cancer Center-West Lakes
Clive, Iowa, 50325
Status
Address
UI Health Care Mission Cancer and Blood - West Des Moines Clinic
Clive, Iowa, 50325
Status
Address
Heartland Oncology and Hematology LLP
Council Bluffs, Iowa, 51503
Status
Address
Methodist Jennie Edmundson Hospital
Council Bluffs, Iowa, 51503
Status
Address
Greater Regional Medical Center
Creston, Iowa, 50801
Status
Address
Iowa Methodist Medical Center
Des Moines, Iowa, 50309
Status
Address
UI Health Care Mission Cancer and Blood - Des Moines Clinic
Des Moines, Iowa, 50309
Status
Address
Broadlawns Medical Center
Des Moines, Iowa, 50314
Status
Address
Mercy Medical Center - Des Moines
Des Moines, Iowa, 50314
Status
Address
UI Health Care Mission Cancer and Blood - Laurel Clinic
Des Moines, Iowa, 50314
Status
Address
Trinity Regional Medical Center
Fort Dodge, Iowa, 50501
Status
Address
University of Iowa/Holden Comprehensive Cancer Center
Iowa City, Iowa, 52242
Status
Address
Mercy Medical Center-West Lakes
West Des Moines, Iowa, 50266
Status
Address
University of Kentucky/Markey Cancer Center
Lexington, Kentucky, 40536
Status
Address
LSU Health Baton Rouge-North Clinic
Baton Rouge, Louisiana, 70805
Status
Address
Our Lady of the Lake Physician Group
Baton Rouge, Louisiana, 70808
Status
Address
Our Lady of The Lake
Baton Rouge, Louisiana, 70808
Status
Address
Louisiana Hematology Oncology Associates LLC
Baton Rouge, Louisiana, 70809
Status
Address
Mary Bird Perkins Cancer Center
Baton Rouge, Louisiana, 70809
Status
Address
Northshore Oncology Associates-Covington
Covington, Louisiana, 70433
Status
Address
Oncology Center of The South Incorporated
Houma, Louisiana, 70360
Status
Address
Brigham and Women's Hospital
Boston, Massachusetts, 02115
Status
Address
Boston Medical Center
Boston, Massachusetts, 02118
Status
Address
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215
Status
Address
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215
Status
Address
Lahey Hospital and Medical Center
Burlington, Massachusetts, 01805
Status
Address
Hickman Cancer Center
Adrian, Michigan, 49221
Status
Address
Trinity Health Saint Joseph Mercy Hospital Ann Arbor
Ann Arbor, Michigan, 48106
Status
Address
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48109
Status
Address
Bronson Battle Creek
Battle Creek, Michigan, 49017
Status
Address
Trinity Health IHA Medical Group Hematology Oncology - Brighton
Brighton, Michigan, 48114
Status
Address
Trinity Health Medical Center - Brighton
Brighton, Michigan, 48114
Status
Address
Trinity Health IHA Medical Group Hematology Oncology - Canton
Canton, Michigan, 48188
Status
Address
Trinity Health Medical Center - Canton
Canton, Michigan, 48188
Status
Address
Caro Cancer Center
Caro, Michigan, 48723
Status
Address
Chelsea Hospital
Chelsea, Michigan, 48118
Status
Address
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
Chelsea, Michigan, 48118
Status
Address
Hematology Oncology Consultants-Clarkston
Clarkston, Michigan, 48346
Status
Address
McLaren Cancer Institute-Clarkston
Clarkston, Michigan, 48346
Status
Address
Newland Medical Associates-Clarkston
Clarkston, Michigan, 48346
Status
Address
Wayne State University/Karmanos Cancer Institute
Detroit, Michigan, 48201
Status
Address
Henry Ford Hospital
Detroit, Michigan, 48202
Status
Address
Henry Ford Health Saint John Hospital
Detroit, Michigan, 48236
Status
Address
Henry Ford River District Hospital
East China Township, Michigan, 48054
Status
Address
Weisberg Cancer Treatment Center
Farmington Hills, Michigan, 48334
Status
Address
Cancer Hematology Centers - Flint
Flint, Michigan, 48503
Status
Address
Genesee Hematology Oncology PC
Flint, Michigan, 48503
Status
Address
Genesys Hurley Cancer Institute
Flint, Michigan, 48503
Status
Address
Hurley Medical Center
Flint, Michigan, 48503
Status
Address
McLaren Cancer Institute-Flint
Flint, Michigan, 48532
Status
Address
Singh and Arora Hematology Oncology PC
Flint, Michigan, 48532
Status
Address
Henry Ford Saint John Hospital - Academic
Grosse Pointe Woods, Michigan, 48236
Status
Address
Henry Ford Saint John Hospital - Breast
Grosse Pointe Woods, Michigan, 48236
Status
Address
Henry Ford Saint John Hospital - Van Elslander
Grosse Pointe Woods, Michigan, 48236
Status
Address
Bronson Methodist Hospital
Kalamazoo, Michigan, 49007
Status
Address
West Michigan Cancer Center
Kalamazoo, Michigan, 49007
Status
Address
Ascension Borgess Cancer Center
Kalamazoo, Michigan, 49009
Status
Address
Karmanos Cancer Institute at McLaren Greater Lansing
Lansing, Michigan, 48910
Status
Address
University of Michigan Health - Sparrow Lansing
Lansing, Michigan, 48912
Status
Address
Hope Cancer Clinic
Livonia, Michigan, 48154
Status
Address
Trinity Health Saint Mary Mercy Livonia Hospital
Livonia, Michigan, 48154
Status
Address
Henry Ford Saint John Hospital - Macomb Medical
Macomb, Michigan, 48044
Status
Address
Henry Ford Warren Hospital - Breast Macomb
Macomb, Michigan, 48044
Status
Address
Saint Mary's Oncology/Hematology Associates of Marlette
Marlette, Michigan, 48453
Status
Address
Toledo Clinic Cancer Centers-Monroe
Monroe, Michigan, 48162
Status
Address
McLaren Cancer Institute-Macomb
Mount Clemens, Michigan, 48043
Status
Address
McLaren Cancer Institute-Central Michigan
Mount Pleasant, Michigan, 48858
Status
Address
McLaren Cancer Institute-Northern Michigan
Petoskey, Michigan, 49770
Status
Address
Hope Cancer Center
Pontiac, Michigan, 48341
Status
Address
Michigan Healthcare Professionals Pontiac
Pontiac, Michigan, 48341
Status
Address
Newland Medical Associates-Pontiac
Pontiac, Michigan, 48341
Status
Address
Trinity Health Saint Joseph Mercy Oakland Hospital
Pontiac, Michigan, 48341
Status
Address
Huron Medical Center PC
Port Huron, Michigan, 48060
Status
Address
Lake Huron Medical Center
Port Huron, Michigan, 48060
Status
Address
McLaren-Port Huron
Port Huron, Michigan, 48060
Status
Address
Henry Ford Rochester Hospital
Rochester Hills, Michigan, 48309
Status
Address
MyMichigan Medical Center Saginaw
Saginaw, Michigan, 48601
Status
Address
Oncology Hematology Associates of Saginaw Valley PC
Saginaw, Michigan, 48604
Status
Address
Bhadresh Nayak MD PC-Sterling Heights
Sterling Heights, Michigan, 48312
Status
Address
MyMichigan Medical Center Tawas
Tawas City, Michigan, 48764
Status
Address
Advanced Breast Care Center PLLC
Warren, Michigan, 48088
Status
Address
Henry Ford Health Warren Hospital
Warren, Michigan, 48093
Status
Address
Henry Ford Madison Heights Hospital - Breast
Warren, Michigan, 48093
Status
Address
Henry Ford Warren Hospital - GLCMS
Warren, Michigan, 48093
Status
Address
Macomb Hematology Oncology PC
Warren, Michigan, 48093
Status
Address
Saint Mary's Oncology/Hematology Associates of West Branch
West Branch, Michigan, 48661
Status
Address
Huron Gastroenterology PC
Ypsilanti, Michigan, 48106
Status
Address
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
Ypsilanti, Michigan, 48197
Status
Address
Sanford Joe Lueken Cancer Center
Bemidji, Minnesota, 56601
Status
Address
Fairview Ridges Hospital
Burnsville, Minnesota, 55337
Status
Address
Minnesota Oncology - Burnsville
Burnsville, Minnesota, 55337
Status
Address
Mercy Hospital
Coon Rapids, Minnesota, 55433
Status
Address
Essentia Health - Deer River Clinic
Deer River, Minnesota, 56636
Status
Address
Essentia Health Cancer Center
Duluth, Minnesota, 55805
Status
Address
Fairview Southdale Hospital
Edina, Minnesota, 55435
Status
Address
Unity Hospital
Fridley, Minnesota, 55432
Status
Address
Essentia Health Hibbing Clinic
Hibbing, Minnesota, 55746
Status
Address
Fairview Clinics and Surgery Center Maple Grove
Maple Grove, Minnesota, 55369
Status
Address
Minnesota Oncology Hematology PA-Maplewood
Maplewood, Minnesota, 55109
Status
Address
Saint John's Hospital - Healtheast
Maplewood, Minnesota, 55109
Status
Address
Abbott-Northwestern Hospital
Minneapolis, Minnesota, 55407
Status
Address
Hennepin County Medical Center
Minneapolis, Minnesota, 55415
Status
Address
Health Partners Inc
Minneapolis, Minnesota, 55454
Status
Address
New Ulm Medical Center
New Ulm, Minnesota, 56073
Status
Address
North Memorial Medical Health Center
Robbinsdale, Minnesota, 55422
Status
Address
Mayo Clinic in Rochester
Rochester, Minnesota, 55905
Status
Address
Park Nicollet Clinic - Saint Louis Park
Saint Louis Park, Minnesota, 55416
Status
Address
Regions Hospital
Saint Paul, Minnesota, 55101
Status
Address
United Hospital
Saint Paul, Minnesota, 55102
Status
Address
Essentia Health Sandstone
Sandstone, Minnesota, 55072
Status
Address
Saint Francis Regional Medical Center
Shakopee, Minnesota, 55379
Status
Address
Lakeview Hospital
Stillwater, Minnesota, 55082
Status
Address
Essentia Health Virginia Clinic
Virginia, Minnesota, 55792
Status
Address
Ridgeview Medical Center
Waconia, Minnesota, 55387
Status
Address
Rice Memorial Hospital
Willmar, Minnesota, 56201
Status
Address
Minnesota Oncology Hematology PA-Woodbury
Woodbury, Minnesota, 55125
Status
Address
Fairview Lakes Medical Center
Wyoming, Minnesota, 55092
Status
Address
Parkland Health Center-Bonne Terre
Bonne Terre, Missouri, 63628
Status
Address
Saint Francis Medical Center
Cape Girardeau, Missouri, 63703
Status
Address
Siteman Cancer Center at West County Hospital
Creve Coeur, Missouri, 63141
Status
Address
Parkland Health Center - Farmington
Farmington, Missouri, 63640
Status
Address
Washington University School of Medicine
Saint Louis, Missouri, 63110
Status
Address
Siteman Cancer Center-South County
Saint Louis, Missouri, 63129
Status
Address
Missouri Baptist Medical Center
Saint Louis, Missouri, 63131
Status
Address
Siteman Cancer Center at Christian Hospital
Saint Louis, Missouri, 63136
Status
Address
Siteman Cancer Center at Saint Peters Hospital
Saint Peters, Missouri, 63376
Status
Address
Sainte Genevieve County Memorial Hospital
Sainte Genevieve, Missouri, 63670
Status
Address
Missouri Baptist Sullivan Hospital
Sullivan, Missouri, 63080
Status
Address
BJC Outpatient Center at Sunset Hills
Sunset Hills, Missouri, 63127
Status
Address
Community Hospital of Anaconda
Anaconda, Montana, 59711
Status
Address
Billings Clinic Cancer Center
Billings, Montana, 59101
Status
Address
Saint Vincent Frontier Cancer Center
Billings, Montana, 59102
Status
Address
Bozeman Health Deaconess Hospital
Bozeman, Montana, 59715
Status
Address
Saint James Community Hospital and Cancer Treatment Center
Butte, Montana, 59701
Status
Address
Benefis Sletten Cancer Institute
Great Falls, Montana, 59405
Status
Address
Great Falls Clinic
Great Falls, Montana, 59405
Status
Address
Saint Peter's Community Hospital
Helena, Montana, 59601
Status
Address
Logan Health Medical Center
Kalispell, Montana, 59901
Status
Address
Community Medical Center
Missoula, Montana, 59804
Status
Address
Nebraska Cancer Specialists/Oncology Hematology West PC
Grand Island, Nebraska, 68803
Status
Address
Nebraska Cancer Specialists/Oncology Hematology West PC - MECC
Omaha, Nebraska, 68114
Status
Address
Nebraska Methodist Hospital
Omaha, Nebraska, 68114
Status
Address
Oncology Associates PC
Omaha, Nebraska, 68114
Status
Address
Carson Tahoe Regional Medical Center
Carson City, Nevada, 89703
Status
Address
Cancer and Blood Specialists-Henderson
Henderson, Nevada, 89052
Status
Address
Comprehensive Cancer Centers of Nevada - Henderson
Henderson, Nevada, 89052
Status
Address
Comprehensive Cancer Centers of Nevada-Horizon Ridge
Henderson, Nevada, 89052
Status
Address
Las Vegas Cancer Center-Henderson
Henderson, Nevada, 89052
Status
Address
OptumCare Cancer Care at Seven Hills
Henderson, Nevada, 89052
Status
Address
Comprehensive Cancer Centers of Nevada-Southeast Henderson
Henderson, Nevada, 89074
Status
Address
GenesisCare USA - Henderson
Henderson, Nevada, 89074
Status
Address
Desert West Surgery
Las Vegas, Nevada, 89102
Status
Address
OptumCare Cancer Care at Charleston
Las Vegas, Nevada, 89102
Status
Address
University Medical Center of Southern Nevada
Las Vegas, Nevada, 89102
Status
Address
Hope Cancer Care of Nevada
Las Vegas, Nevada, 89103
Status
Address
Cancer and Blood Specialists-Shadow
Las Vegas, Nevada, 89106
Status
Address
Radiation Oncology Centers of Nevada Central
Las Vegas, Nevada, 89106
Status
Address
GenesisCare USA - Las Vegas
Las Vegas, Nevada, 89109
Status
Address
HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway
Las Vegas, Nevada, 89109
Status
Address
HealthCare Partners Medical Group Oncology/Hematology-San Martin
Las Vegas, Nevada, 89113
Status
Address
Radiation Oncology Centers of Nevada Southeast
Las Vegas, Nevada, 89119
Status
Address
Cancer Therapy and Integrative Medicine
Las Vegas, Nevada, 89121
Status
Address
Ann M Wierman MD LTD
Las Vegas, Nevada, 89128
Status
Address
Cancer and Blood Specialists-Tenaya
Las Vegas, Nevada, 89128
Status
Address
Comprehensive Cancer Centers of Nevada - Northwest
Las Vegas, Nevada, 89128
Status
Address
GenesisCare USA - Vegas Tenaya
Las Vegas, Nevada, 89128
Status
Address
HealthCare Partners Medical Group Oncology/Hematology-Tenaya
Las Vegas, Nevada, 89128
Status
Address
OptumCare Cancer Care at MountainView
Las Vegas, Nevada, 89128
Status
Address
Comprehensive Cancer Centers of Nevada-Summerlin
Las Vegas, Nevada, 89144
Status
Address
Summerlin Hospital Medical Center
Las Vegas, Nevada, 89144
Status
Address
Las Vegas Cancer Center-Medical Center
Las Vegas, Nevada, 89148-2405
Status
Address
Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, 89148
Status
Address
GenesisCare USA - Fort Apache
Las Vegas, Nevada, 89148
Status
Address
OptumCare Cancer Care at Fort Apache
Las Vegas, Nevada, 89148
Status
Address
HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills
Las Vegas, Nevada, 89149
Status
Address
Comprehensive Cancer Centers of Nevada - Central Valley
Las Vegas, Nevada, 89169
Status
Address
University Cancer Center
Las Vegas, Nevada, 89169
Status
Address
Hope Cancer Care of Nevada-Pahrump
Pahrump, Nevada, 89048
Status
Address
Renown Regional Medical Center
Reno, Nevada, 89502
Status
Address
Saint Mary's Regional Medical Center
Reno, Nevada, 89503
Status
Address
Radiation Oncology Associates
Reno, Nevada, 89509
Status
Address
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
Lebanon, New Hampshire, 03756
Status
Address
Dartmouth Cancer Center - Nashua
Nashua, New Hampshire, 03063
Status
Address
Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey, 07920
Status
Address
Englewood Hospital and Medical Center
Englewood, New Jersey, 07631
Status
Address
Memorial Sloan Kettering Monmouth
Middletown, New Jersey, 07748
Status
Address
Memorial Sloan Kettering Bergen
Montvale, New Jersey, 07645
Status
Address
The Valley Hospital - Luckow Pavilion
Paramus, New Jersey, 07652
Status
Address
Valley Health System Ridgewood Campus
Ridgewood, New Jersey, 07450
Status
Address
Valley Medical Group - Wayne Multispecialty Practice
Wayne, New Jersey, 07470
Status
Address
University of New Mexico Cancer Center
Albuquerque, New Mexico, 87106
Status
Address
New Mexico Oncology Hematology Consultants
Albuquerque, New Mexico, 87109
Status
Address
Presbyterian Kaseman Hospital
Albuquerque, New Mexico, 87110
Status
Address
Presbyterian Rust Medical Center/Jorgensen Cancer Center
Rio Rancho, New Mexico, 87124
Status
Address
Hematology Oncology Associates of Central New York-Auburn
Auburn, New York, 13021
Status
Address
Roswell Park Cancer Institute
Buffalo, New York, 14263
Status
Address
Hematology Oncology Associates of CNY at Camillus
Camillus, New York, 13031
Status
Address
Memorial Sloan Kettering Commack
Commack, New York, 11725
Status
Address
Hematology Oncology Associates of Central New York-East Syracuse
East Syracuse, New York, 13057
Status
Address
Memorial Sloan Kettering Westchester
Harrison, New York, 10604
Status
Address
Mount Sinai Hospital
New York, New York, 10029
Status
Address
Memorial Sloan Kettering Cancer Center
New York, New York, 10065
Status
Address
University of Rochester
Rochester, New York, 14642
Status
Address
Memorial Sloan Kettering Nassau
Uniondale, New York, 11553
Status
Address
Wilmot Cancer Institute at Webster
Webster, New York, 14580
Status
Address
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27599
Status
Address
Southeastern Medical Oncology Center-Clinton
Clinton, North Carolina, 28328
Status
Address
Southeastern Medical Oncology Center-Goldsboro
Goldsboro, North Carolina, 27534
Status
Address
Margaret R Pardee Memorial Hospital
Hendersonville, North Carolina, 28791
Status
Address
Southeastern Medical Oncology Center-Jacksonville
Jacksonville, North Carolina, 28546
Status
Address
ECU Health Oncology Kinston
Kinston, North Carolina, 28501
Status
Address
Marion L Shepard Cancer Center - ECU Health Beaufort Hospital
Washington, North Carolina, 27889
Status
Address
Sanford Bismarck Medical Center
Bismarck, North Dakota, 58501
Status
Address
Sanford Broadway Medical Center
Fargo, North Dakota, 58122
Status
Address
Sanford Roger Maris Cancer Center
Fargo, North Dakota, 58122
Status
Address
UHHS-Chagrin Highlands Medical Center
Beachwood, Ohio, 44122
Status
Address
Strecker Cancer Center-Belpre
Belpre, Ohio, 45714
Status
Address
Miami Valley Hospital South
Centerville, Ohio, 45459
Status
Address
Adena Regional Medical Center
Chillicothe, Ohio, 45601
Status
Address
Case Western Reserve University
Cleveland, Ohio, 44106
Status
Address
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210
Status
Address
Columbus Oncology and Hematology Associates Inc
Columbus, Ohio, 43214
Status
Address
Grant Medical Center
Columbus, Ohio, 43215
Status
Address
The Mark H Zangmeister Center
Columbus, Ohio, 43219
Status
Address
Doctors Hospital
Columbus, Ohio, 43228
Status
Address
Miami Valley Hospital
Dayton, Ohio, 45409
Status
Address
Premier Blood and Cancer Center
Dayton, Ohio, 45409
Status
Address
Miami Valley Hospital North
Dayton, Ohio, 45415
Status
Address
Delaware Health Center-Grady Cancer Center
Delaware, Ohio, 43015
Status
Address
Atrium Medical Center-Middletown Regional Hospital
Franklin, Ohio, 45005-1066
Status
Address
OhioHealth Mansfield Hospital
Mansfield, Ohio, 44903
Status
Address
Marietta Memorial Hospital
Marietta, Ohio, 45750
Status
Address
OhioHealth Marion General Hospital
Marion, Ohio, 43302
Status
Address
Toledo Clinic Cancer Centers-Maumee
Maumee, Ohio, 43537
Status
Address
Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
Maumee, Ohio, 43537
Status
Address
UH Seidman Cancer Center at Lake Health Mentor Campus
Mentor, Ohio, 44060
Status
Address
UH Seidman Cancer Center at Southwest General Hospital
Middleburg Heights, Ohio, 44130
Status
Address
Licking Memorial Hospital
Newark, Ohio, 43055
Status
Address
University Hospitals Parma Medical Center
Parma, Ohio, 44129
Status
Address
Mercy Health - Perrysburg Hospital
Perrysburg, Ohio, 43551
Status
Address
Southern Ohio Medical Center
Portsmouth, Ohio, 45662
Status
Address
Mercy Health - Saint Anne Hospital
Toledo, Ohio, 43623
Status
Address
Toledo Clinic Cancer Centers-Toledo
Toledo, Ohio, 43623
Status
Address
Upper Valley Medical Center
Troy, Ohio, 45373
Status
Address
University Hospitals Sharon Health Center
Wadsworth, Ohio, 44281
Status
Address
UH Seidman Cancer Center at Saint John Medical Center
Westlake, Ohio, 44145
Status
Address
Genesis Healthcare System Cancer Care Center
Zanesville, Ohio, 43701
Status
Address
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104
Status
Address
Oklahoma Cancer Specialists and Research Institute-Tulsa
Tulsa, Oklahoma, 74146
Status
Address
Saint Alphonsus Cancer Care Center-Baker City
Baker City, Oregon, 97814
Status
Address
Providence Cancer Institute Clackamas Clinic
Clackamas, Oregon, 97015
Status
Address
Providence Newberg Medical Center
Newberg, Oregon, 97132
Status
Address
Saint Alphonsus Cancer Care Center-Ontario
Ontario, Oregon, 97914
Status
Address
Providence Portland Medical Center
Portland, Oregon, 97213
Status
Address
Providence Saint Vincent Medical Center
Portland, Oregon, 97225
Status
Address
Lehigh Valley Hospital-Cedar Crest
Allentown, Pennsylvania, 18103
Status
Address
Lehigh Valley Hospital - Muhlenberg
Bethlehem, Pennsylvania, 18017
Status
Address
Pocono Medical Center
East Stroudsburg, Pennsylvania, 18301
Status
Address
Saint Vincent Hospital
Erie, Pennsylvania, 16544
Status
Address
Lehigh Valley Hospital-Hazleton
Hazleton, Pennsylvania, 18201
Status
Address
Jefferson Hospital
Jefferson Hills, Pennsylvania, 15025
Status
Address
Forbes Hospital
Monroeville, Pennsylvania, 15146
Status
Address
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107
Status
Address
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111
Status
Address
Temple University Hospital
Philadelphia, Pennsylvania, 19140
Status
Address
Allegheny General Hospital
Pittsburgh, Pennsylvania, 15212
Status
Address
West Penn Hospital
Pittsburgh, Pennsylvania, 15224
Status
Address
Wexford Health and Wellness Pavilion
Wexford, Pennsylvania, 15090
Status
Address
Prisma Health Cancer Institute - Spartanburg
Boiling Springs, South Carolina, 29316
Status
Address
Prisma Health Cancer Institute - Easley
Easley, South Carolina, 29640
Status
Address
Prisma Health Cancer Institute - Butternut
Greenville, South Carolina, 29605
Status
Address
Prisma Health Cancer Institute - Faris
Greenville, South Carolina, 29605
Status
Address
Prisma Health Cancer Institute - Eastside
Greenville, South Carolina, 29615
Status
Address
Prisma Health Cancer Institute - Greer
Greer, South Carolina, 29650
Status
Address
Prisma Health Cancer Institute - Seneca
Seneca, South Carolina, 29672
Status
Address
Sanford Cancer Center Oncology Clinic
Sioux Falls, South Dakota, 57104
Status
Address
Sanford USD Medical Center - Sioux Falls
Sioux Falls, South Dakota, 57117-5134
Status
Address
Farmington Health Center
Farmington, Utah, 84025
Status
Address
University of Utah Sugarhouse Health Center
Salt Lake City, Utah, 84106
Status
Address
Huntsman Cancer Institute/University of Utah
Salt Lake City, Utah, 84112
Status
Address
Virginia Mason Medical Center
Seattle, Washington, 98101
Status
Address
Edwards Comprehensive Cancer Center
Huntington, West Virginia, 25701
Status
Address
West Virginia University Healthcare
Morgantown, West Virginia, 26506
Status
Address
ThedaCare Regional Cancer Center
Appleton, Wisconsin, 54911
Status
Address
Duluth Clinic Ashland
Ashland, Wisconsin, 54806
Status
Address
Marshfield Medical Center-EC Cancer Center
Eau Claire, Wisconsin, 54701
Status
Address
University of Wisconsin Carbone Cancer Center - University Hospital
Madison, Wisconsin, 53792
Status
Address
Marshfield Medical Center-Marshfield
Marshfield, Wisconsin, 54449
Status
Address
Marshfield Medical Center - Minocqua
Minocqua, Wisconsin, 54548
Status
Address
ProHealth D N Greenwald Center
Mukwonago, Wisconsin, 53149
Status
Address
Cancer Center of Western Wisconsin
New Richmond, Wisconsin, 54017
Status
Address
ProHealth Oconomowoc Memorial Hospital
Oconomowoc, Wisconsin, 53066
Status
Address
Marshfield Medical Center-Rice Lake
Rice Lake, Wisconsin, 54868
Status
Address
Marshfield Medical Center-River Region at Stevens Point
Stevens Point, Wisconsin, 54482
Status
Address
ProHealth Waukesha Memorial Hospital
Waukesha, Wisconsin, 53188
Status
Address
UW Cancer Center at ProHealth Care
Waukesha, Wisconsin, 53188
Status
Address
Marshfield Medical Center - Weston
Weston, Wisconsin, 54476
Status
Address
Billings Clinic-Cody
Cody, Wyoming, 82414
Status
Address
Welch Cancer Center
Sheridan, Wyoming, 82801
